| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $54.5M | +3.9% | -32.4% |
| Cost of Revenue | $12.2M | -1.0% | -58.2% |
| R&D Expense | $15.9M | +3.0% | +26.8% |
| SG&A Expense | $16.8M | -6.8% | -0.0% |
| Operating Income | $9.6M | +44.3% | -56.6% |
| Pre-tax Income | $9.2M | +49.9% | -55.1% |
| Net Income | $8.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $53.5M | -2.1% | -20.4% |
| Short-term Investments | $40.9M | -1.2% | +38.7% |
| Accounts Receivable | $33.6M | +29.5% | -38.6% |
| Inventory | $9.5M | +10.3% | +254.5% |
| Current Assets | $143.6M | +5.1% | -8.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $27.4M | — | — |
| Capital Expenditures | $107K | — | — |
| Investing Cash Flow | -$9.2M | — | — |
| Financing Cash Flow | -$33.9M | — | — |
| Free Cash Flow | $27.3M | — | — |
| +51.1% |
| -56.5% |
| EPS (Basic) | $0.18 | +50.0% | -56.1% |
| EPS (Diluted) | $0.17 | +41.7% | -58.5% |
| $202.9M |
| +4.1% |
| -8.1% |
| Current Liabilities | $82.7M | +4.6% | -25.1% |
| Long-term Debt | $34.0M | -25.0% | -57.1% |
| Total Liabilities | $87.6M | -2.9% | -41.5% |
| Stockholders' Equity | $115.3M | +10.1% | +62.1% |